High-dose IL-2 induces rapid albumin uptake by endothelial cells through Src-dependent caveolae-mediated endocytosis

Andrew Zloza, Dae W.on Kim, Joseph Broucek, Jason M Schenkel, Howard L. Kaufman

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

High-dose interleukin-2 (HDIL2) treatment of patients with metastatic melanoma and renal cell carcinoma is associated with durable responses, but therapy is accompanied by significant toxicity related to vascular leak syndrome (VLS). Currently, the cause of VLS is not well defined; however, based on the role of endothelial cell (EC) permeability in VLS and the commonly observed hypoalbuminemia in patients receiving HDIL2 therapy, we established an in vitro approach utilizing primary human pulmonary microvascular ECs to monitor the effect of HDIL2 therapy on albumin uptake. We found that HDIL2 treatment of ECs results in albumin colocalization with caveolin-1 leading to albumin uptake by ECs. This albumin uptake occurs through caveolae-mediated but not clathrin-mediated endocytosis and is abrogated with inhibition of the Src tyrosine kinase pathway. These findings provide insight into how IL-2 induces VLS and may help identify potential targets for prevention of toxicity without affecting the therapeutic activity of HDIL2.

Original languageEnglish (US)
Pages (from-to)915-919
Number of pages5
JournalJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Volume34
Issue number11
DOIs
StatePublished - Nov 1 2014

Fingerprint Dive into the research topics of 'High-dose IL-2 induces rapid albumin uptake by endothelial cells through Src-dependent caveolae-mediated endocytosis'. Together they form a unique fingerprint.

Cite this